SANUWAVE Health Inc (NAS:SNWV)
$ 6.07 -0.43 (-6.69%) Market Cap: 52.15 Mil Enterprise Value: 63.54 Mil PE Ratio: 18.38 PB Ratio: 28.88 GF Score: 34/100

Q2 2025 SANUWAVE Health Inc Earnings Call Transcript

Aug 08, 2025 / 12:30PM GMT
Release Date Price: $39.76 (+15.85%)

Key Points

Positve
  • SANUWAVE Health Inc (SNWV) reported a 42% year-over-year increase in revenue for Q2 2025, reaching a new quarterly record.
  • The company sold 116 UltraMIST systems in Q2, marking a 61% increase compared to the previous year.
  • Gross margins remained strong at 78.3%, up 510 basis points from the previous year.
  • The company has expanded its sales force to cover all 12 national sales territories, enhancing its commercial reach.
  • SANUWAVE Health Inc (SNWV) is preparing for its first-ever concerted outbound marketing campaign, expected to launch in October, to further drive product adoption.
Negative
  • Operating expenses increased significantly to $6.1 million in Q2 2025 from $3.2 million in the same period last year, driven by non-cash stock-based compensation and other factors.
  • Net income decreased to $1.1 million in Q2 2025 from $6.6 million in Q2 2024, primarily due to lower non-cash and infrequent items.
  • The company faces challenges in forecasting large customer sales, which impacts revenue guidance accuracy.
  • The transition to a new applicator design will take time to impact gross margins due to existing inventory levels.
  • The company is still in the early stages of engaging with large accounts, making it difficult to predict the timing and scale of potential sales.
Operator

Good day, everyone, and welcome to the SANUWAVE Q2 earnings call. (Operator Instructions) Please note this call may be recorded (Operator Instructions) It is now my pleasure to turn the conference over to Morgan Frank, Chairman and CEO of SANUWAVE. Please go ahead.

Morgan Frank
SANUWAVE Health Inc - Chairman of the Board, Chief Executive Officer

Thank you very much. Good morning, and welcome to SANUWAVE's second quarter 2021 earnings call. Our Form 10-Q was filed with the SEC last night, and our earnings release we issued this morning, along with our updated presentation, which was made available on our website in the investors section. It's useful to refer to this during the presentation. It really does provide useful information, I promise.

So joining on the call this morning is Peter Sorensen, our CFO. And after the presentation, we will open the call up to Q&A. We'll begin with everybody's favorite, forward-looking statements and other disclosures. This call may contain forward-looking statements. Such are statements referring to our future

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot